Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 11096204 | HLA-DR (HLA-DR) | malignant neoplasm | Caucasian | NA | NA | unclassified | |
| a 72-year-old caucasian man presented with a malignant neoplasm comprised of blastoid cells without azurophilic granules in the giemsa stain, with positivity for cd2, cd4, hla-dr, cd45 and cd56, and negativity for cd3 (surface and cytoplasmic) and cd5. | |||||||
| 30186855 | HLA-DRB1 (HLA-DRB1) | staphylococcus aureus infection | NA | NA | NA | positive | |
| hla-drb1, hla-drb5, c3, and icam were significantly involved in staphylococcus aureus infection. | |||||||
| 11132167 | HLA-DR (HLA-DR) | stable angina | NA | NA | NA | unclassified | |
| we analyzed plasma c-reactive protein (crp) levels and the expression levels of cd14 and cd11b on monocytes and the percentage of hla-dr t-lymphocytes in 25 patients with acute coronary syndrome (acs), 12 stable angina (sa) patients, and 23 control subjects using flow-cytometry. | |||||||
| 11132167 | HLA-DR (HLA-DR) | acute coronary syndrome | NA | NA | NA | unclassified | |
| we analyzed plasma c-reactive protein (crp) levels and the expression levels of cd14 and cd11b on monocytes and the percentage of hla-dr t-lymphocytes in 25 patients with acute coronary syndrome (acs), 12 stable angina (sa) patients, and 23 control subjects using flow-cytometry. | |||||||
| 11578706 | HLA-DR (HLA-DR) | acute coronary syndrome | NA | NA | NA | unclassified | |
| a significantly higher percentage of hla-dr positive t-lymphocytes (20.4+/-9.0 vs. 12.7+/-3.7%, p<0.01) was observed in acute coronary syndrome patients in comparison to control subjects. | |||||||
| 11578706 | HLA-DR (HLA-DR) | acute coronary syndrome | NA | NA | NA | positive | |
| when these markers of activation were measured in acute coronary syndrome patients 6 weeks after medical treatment, a significant reduction both in monocytic cd14 expression and percentage of hla-dr positive t-lymphocytes (p<0.05 for both) was observed. | |||||||
| 26679868 | HLA-DRB1*01 | acute coronary syndrome | European | NA | NA | unclassified | |
| the hla-drb1*01 allele of the human leukocyte antigen has been associated with acute coronary syndrome. | |||||||
| 26679868 | HLA-DRB1*01 | acute coronary syndrome | European | NA | NA | unclassified | |
| we analyzed the risk candidate allele of hla-drb1*01 by genomic real-time polymerase chain reaction together with high-density single nucleotide polymorphisms of the major histocompatibility complex to precisely identify risk loci for acute coronary syndrome with effective clinical implications. | |||||||
| 28982023 | HLA-DR (HLA-DR) | acute coronary syndrome | NA | NA | NA | negation | |
| soluble hla-dr serum levels are associated with smoking but not with acute coronary syndrome. | |||||||
| 28982023 | HLA-DRB1*01 | acute coronary syndromes | NA | NA | NA | unclassified | |
| we have previously shown that the hla class ii allele hla-drb1*01 may predispose to acute coronary syndromes (acs). | |||||||
Copyright 2024